Physician profile
Adam D Shellito
NPI 1750793667
$3,861.47
in general payments reported to CMS, 2019-2025
14 companies · $1,206 in 2025
The $1,206 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2021: $87.47 · 2022: $1,120 · 2023: $1,116 · 2024: $90.21 · 2025: $1,206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,915 · Food and Beverage: $498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,914.87 |
| Food and Beverage | $497.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,322.19 | 2022-2025 | Da Vinci Surgical System |
| Acell, INC. | $107.46 | 2019 | |
| Aroa Biosurgery Incorporated | $97.40 | 2022 | |
| Tesaro, INC. | $52.24 | 2019 | |
| Abbott Laboratories | $47.64 | 2021 | |
| Mallinckrodt Enterprises LLC | $42.50 | 2019 | |
| Teleflex LLC | $38.77 | 2024 | Solesta |
| Coloplast Corp | $27.46 | 2024 | |
| Musculoskeletal Transplant Foundation INC. | $24.51 | 2021-2022 | |
| Allergan, INC. | $24.12 | 2021 | |
| Integra Lifesciences Corporation | $23.98 | 2024 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Novartis Pharmaceuticals Corporation | $23.59 | 2019 | |
| Ethicon US, LLC | $15.57 | 2019 | |
| W. L. Gore & Associates, INC. | $14.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Shellito listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.